Literature DB >> 183085

Low density lipoprotein metabolism in a family of familial hypercholesterolemic patients.

C J Packard, J L Third, J Shepherd, A R Lorimer, H G Morgan, T D Lawrie.   

Abstract

A low-density lipoprotein turnover study was performed on six heteroxygous familial hypercholesterolemic subjects and five control subjects. The diagnosis of the condition was clear-cut on biochemical, clinical, and genetic grounds. Kinetic analysis of the plasma decay curves gave the following mean values: (1) The plasma concentration of low density lipoprotein apoprotein (apoLDL) in the affected subjects was 247 mg/dl, a 2.5-fold increase over control values (98 mg/dl). (2) The calculated fractional catabolic rate of the intravascular apoLDL pool in the dyslipo-proteniemics was reduced with respect to control data (16.4%/day versus 31.2%/day), and the half-life of the apolipoprotein was correspondingly increased (6.07 days versus 3.63 days). (3) The absolute catabolic rate of the apoLDL was 15.6 mg/kg/day in contrast to the lower value of 11.6 mg/kg/day in the control group. (4) A strong negative correlation was observed between the plasma apoLDL concentration and the fractional catabolic rate (r = 0.96). We conclude from our data that increased apoLDL synthesis coupled with a defective or saturated catabolic mechanism is implicated in the pathogenesis of familial hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 183085     DOI: 10.1016/0026-0495(76)90129-3

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  14 in total

Review 1.  Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments.

Authors:  Rajasekhar Ramakrishnan
Journal:  J Lipid Res       Date:  2006-09-01       Impact factor: 5.922

2.  Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I.

Authors:  J Shepherd; C J Packard; J R Patsch; A M Gotto; O D Taunton
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

3.  Chemical and kinetic study of the lipoproteins in abetalipoproteinaemic plasma.

Authors:  J Shepherd; M Caslake; E Farish; A Fleck
Journal:  J Clin Pathol       Date:  1978-04       Impact factor: 3.411

4.  Endoplasmic reticulum localization of the low density lipoprotein receptor mediates presecretory degradation of apolipoprotein B.

Authors:  Donald L Gillian-Daniel; Paul W Bates; Angie Tebon; Alan D Attie
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

5.  The role of the LDL receptor in apolipoprotein B secretion.

Authors:  J Twisk; D L Gillian-Daniel; A Tebon; L Wang; P H Barrett; A D Attie
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

6.  Catabolic rate of low density lipoprotein is influenced by variation in the apolipoprotein B gene.

Authors:  T Demant; R S Houlston; M J Caslake; J J Series; J Shepherd; C J Packard; S E Humphries
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

7.  Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects.

Authors:  J Shepherd; C J Packard; J M Stewart; R F Atmeh; R S Clark; D E Boag; K Carr; A R Lorimer; D Ballantyne; H G Morgan
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

8.  Turnover of lipoprotein (a) in man.

Authors:  F Krempler; G M Kostner; K Bolzano; F Sandhofer
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

9.  Significance of low density lipoprotein production in the regulations of plasma cholesterol level in man.

Authors:  Y A Kesaniemi; S M Grundy
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

10.  Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins.

Authors:  W F Beltz; Y A Kesäniemi; B V Howard; S M Grundy
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.